Nivolumab in HIV-related non-small-cell lung cancer

被引：26
|
作者：
Hentrich, M. [1 ]
Schipek-Voigt, K. [2 ]
Jager, H. [3 ]
Schulz, S. [1 ]
Schmid, P. [1 ]
Stotzer, O. [2 ]
Bojko, P. [1 ]
机构：
[1] Red Cross Hosp, Dept Hematol & Oncol, Munich, Germany
[2] MVZ Hematol & Oncol, Dept Hematol & Oncol, Munich, Germany
[3] MUC Res, Ctr Infect Dis, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷 / 11期
关键词：
D O I：
10.1093/annonc/mdx321
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：2890 / 2890
页数：1
相关论文
共 50 条
  • [41] Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
    Rogado, J.
    Fenor De La Maza, M. D.
    Pacheco-Barcia, V.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Ballesteros, A.
    Mondejar, R.
    Donnay, O.
    Obispo, B.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2107 - S2108
  • [42] Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Gettinger, Scott
    Rizvi, Naiyer A.
    Chow, Laura Q.
    Borghaei, Hossein
    Brahmer, Julie
    Ready, Neal
    Gerber, David E.
    Shepherd, Frances A.
    Antonia, Scott
    Goldman, JonathanW.
    Juergens, Rosalyn A.
    Laurie, Scott A.
    Nathan, Faith E.
    Shen, Yun
    Harbison, Christopher T.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 2980 - +
  • [43] Nivolumab for refractory metastatic squamous non-small-cell lung cancer: fulfilling an unmet need
    Marrone, Kristen A.
    Forde, Patrick M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (06) : 801 - 803
  • [44] A Rare Delayed Atypical Pseudoprogression in Nivolumab-Treated Non-Small-Cell Lung Cancer
    Suyanto, Suyanto
    Yeo, Daniel
    Khan, Sarah
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [45] Impact of Oral Drugs on the Prognosis of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
    Taniguchi, Y.
    Tamiya, A.
    Isa, S.
    Nakahama, K.
    Okishio, K.
    Shiroyama, T.
    Suzuki, H.
    Inoue, T.
    Tamiya, M.
    Hirashima, T.
    Imamura, F.
    Atagi, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S390 - S390
  • [46] Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma
    Baba, Tomohisa
    Sakai, Fumikazu
    Kato, Terufumi
    Kusumoto, Masahiko
    Kenmotsu, Hirotsugu
    Sugiura, Hiroaki
    Tominaga, Junya
    Oikado, Katsunori
    Sata, Masafumi
    Endo, Masahiro
    Yanagawa, Noriyo
    Sasaki, Shinichi
    Iwasawa, Tae
    Saito, Yoshinobu
    Fujiwara, Yutaka
    Ohe, Yuichiro
    Yamazaki, Naoya
    Sakamoto, Takahiko
    Koshiba, Takashi
    Kuwano, Kazuyoshi
    FUTURE ONCOLOGY, 2019, 15 (16) : 1911 - 1920
  • [47] Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer
    Rounds, Amanda
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (21) : 1851 - 1855
  • [48] REAL-WORLD DATA OF NIVOLUMAB IN NON-SMALL-CELL LUNG CANCER PATIENTS IN GREECE
    Kourlaba, G.
    Kokkotou, E.
    Papaspiliou, A.
    Stefanou, G.
    Stournara, L.
    Syrigos, K.
    VALUE IN HEALTH, 2019, 22 : S435 - S436
  • [49] Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
    Oya, Yuko
    Yoshida, Tatsuya
    Kuroda, Hiroaki
    Mikubo, Masashi
    Kondo, Chiaki
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    ONCOTARGET, 2017, 8 (61) : 103117 - 103128
  • [50] Real-world evidence of nivolumab for non-small-cell lung cancer in a developing country
    Lujan, Mauricio
    Lema, Mauricio
    Preciado, Beatriz
    Lema, Camila
    Egurrola, Jorge
    Cardona, Andres
    Gonzalez, Diego
    Mantilla, William
    Pino, Luis
    Rojas, Gustavo
    Gomez, Diego
    Munevar, Isabel
    Manneh, Raimundo
    Manneh, Ray
    Lobaton, Jose
    Calle, Esteban
    Borras, Mariana
    Triana, Ivan
    Londono, Paula
    Aruachan, Sandra
    Pineda, Mateo
    Moran, Diego
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (05) : 502 - 510
12345